Comprehensive Stock Comparison
Compare Concord Medical Services Holdings Limited (CCM) vs Apple Inc. (AAPL) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | AAPL | 6.4% revenue growth vs CCM's -28.6% |
| Value | CCM | Lower P/E (0.9x vs 31.1x) |
| Quality / Margins | AAPL | 27.0% net margin vs CCM's -44.6% |
| Stability / Safety | CCM | Beta 0.25 vs AAPL's 1.28 |
| Dividends | AAPL | 0.4% yield; 14-year raise streak; CCM pays no meaningful dividend |
| Momentum (1Y) | AAPL | +9.7% vs CCM's -29.9% |
| Efficiency (ROA) | AAPL | 31.1% ROA vs CCM's -2.4%, ROIC 64.5% vs -7.7% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Concord Medical Services operates a network of radiotherapy and diagnostic imaging centers across China, specializing in cancer treatment services. It generates revenue primarily from operating its network of treatment centers — including linear accelerators and gamma knife systems — and from hospital management services, with additional income from equipment leasing and medical IT services. The company's competitive advantage lies in its established network of specialized cancer treatment facilities across China and its expertise in advanced radiotherapy technologies.
Apple is a technology giant that designs and sells premium consumer electronics — most famously the iPhone — along with related software and services. It generates revenue primarily from hardware sales (roughly 80% of total) and a fast-growing services segment (around 20%) that includes the App Store, subscriptions, and licensing. Its key competitive advantage is a powerful ecosystem that locks users into its hardware, software, and services through seamless integration and high switching costs.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
AAPL leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.
Financial Metrics (TTM)
AAPL is the larger business by revenue, generating $435.6B annually — 1191.0x CCM's $366M. AAPL is the more profitable business, keeping 27.0% of every revenue dollar as net income compared to CCM's -44.6%. On growth, AAPL holds the edge at +15.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CCMConcord Medical S… | AAPLApple Inc. |
|---|---|---|
| RevenueTrailing 12 months | $366M | $435.6B |
| EBITDAEarnings before interest/tax | -$359M | $152.9B |
| Net IncomeAfter-tax profit | -$163M | $117.8B |
| Free Cash FlowCash after capex | $0 | $123.3B |
| Gross MarginGross profit ÷ Revenue | -11.4% | +47.3% |
| Operating MarginEBIT ÷ Revenue | -131.0% | +32.4% |
| Net MarginNet income ÷ Revenue | -44.6% | +27.0% |
| FCF MarginFCF ÷ Revenue | -2.1% | +28.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.3% | +15.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +84.0% | +18.3% |
Valuation Metrics
| Metric | CCMConcord Medical S… | AAPLApple Inc. |
|---|---|---|
| Market CapShares × price | $167M | $3.88T |
| Enterprise ValueMkt cap + debt − cash | $708M | $3.97T |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 35.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.87x | 31.15x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.98x |
| EV / EBITDAEnterprise value multiple | — | 27.45x |
| Price / SalesMarket cap ÷ Revenue | 2.98x | 9.33x |
| Price / BookPrice ÷ Book value/share | 0.00x | 53.76x |
| Price / FCFMarket cap ÷ FCF | — | 39.33x |
Profitability & Efficiency
AAPL delivers a 133.5% return on equity — every $100 of shareholder capital generates $134 in annual profit, vs $-9 for CCM. AAPL carries lower financial leverage with a 1.67x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), AAPL scores 7/9 vs CCM's 3/9, reflecting strong financial health.
| Metric | CCMConcord Medical S… | AAPLApple Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -9.5% | +133.5% |
| ROA (TTM)Return on assets | -2.4% | +31.1% |
| ROICReturn on invested capital | -7.7% | +64.5% |
| ROCEReturn on capital employed | -12.2% | +69.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 |
| Debt / EquityFinancial leverage | 2.43x | 1.67x |
| Net DebtTotal debt minus cash | $3.7B | $89.7B |
| Cash & Equiv.Liquid assets | $216M | $33.5B |
| Total DebtShort + long-term debt | $3.9B | $123.3B |
| Interest CoverageEBIT ÷ Interest expense | -2.40x | — |
Total Returns (with DRIP)
A $10,000 investment in AAPL five years ago would be worth $21,049 today (with dividends reinvested), compared to $992 for CCM. Over the past 12 months, AAPL leads with a +9.7% total return vs CCM's -29.9%. The 3-year compound annual growth rate (CAGR) favors AAPL at 21.9% vs CCM's -36.5% — a key indicator of consistent wealth creation.
| Metric | CCMConcord Medical S… | AAPLApple Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -14.8% | -2.4% |
| 1-Year ReturnPast 12 months | -29.9% | +9.7% |
| 3-Year ReturnCumulative with dividends | -74.4% | +81.2% |
| 5-Year ReturnCumulative with dividends | -90.1% | +110.5% |
| 10-Year ReturnCumulative with dividends | -92.1% | +1027.4% |
| CAGR (3Y)Annualised 3-year return | -36.5% | +21.9% |
Risk & Volatility
CCM is the less volatile stock with a 0.25 beta — it tends to amplify market swings less than AAPL's 1.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AAPL currently trades 91.5% from its 52-week high vs CCM's 33.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CCMConcord Medical S… | AAPLApple Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.25x | 1.28x |
| 52-Week HighHighest price in past year | $10.77 | $288.61 |
| 52-Week LowLowest price in past year | $3.18 | $169.21 |
| % of 52W HighCurrent price vs 52-week peak | +33.8% | +91.5% |
| RSI (14)Momentum oscillator 0–100 | 41.9 | 57.5 |
| Avg Volume (50D)Average daily shares traded | 7K | 40.9M |
Analyst Outlook
Wall Street rates CCM as "Buy" and AAPL as "Buy". AAPL is the only dividend payer here at 0.39% yield — a key consideration for income-focused portfolios.
| Metric | CCMConcord Medical S… | AAPLApple Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $303.11 |
| # AnalystsCovering analysts | 2 | 109 |
| Dividend YieldAnnual dividend ÷ price | — | +0.4% |
| Dividend StreakConsecutive years of raises | 0 | 14 |
| Dividend / ShareAnnual DPS | — | $1.03 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.3% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | 100 | 16.67 | -83.3% |
| Apple Inc. (AAPL) | 100 | 448.3 | +348.3% |
Apple Inc. (AAPL) returned +110% over 5 years vs Concord Medical Ser… (CCM)'s -90%. A $10,000 investment in AAPL 5 years ago would be worth $21,049 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | $455M | $384M | -15.6% |
| Apple Inc. (AAPL) | $215.6B | $416.2B | +93.0% |
Apple Inc.'s revenue grew from $215.6B (2016) to $416.2B (2025) — a 7.6% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | -57.5% | -80.3% | -39.5% |
| Apple Inc. (AAPL) | 21.2% | 26.9% | +27.0% |
Apple Inc.'s net margin went from 21% (2016) to 27% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Apple Inc. (AAPL) | 18.4 | 36.4 | +97.8% |
Apple Inc. has traded in a 13x–41x P/E range over 9 years; current trailing P/E is ~35x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Concord Medical Ser… (CCM) | -1,804.2 | -2,116.8 | -17.3% |
| Apple Inc. (AAPL) | 2.08 | 7.46 | +258.7% |
Apple Inc.'s EPS grew from $2.08 (2016) to $7.46 (2025) — a 15% CAGR.
Chart 6Free Cash Flow — 5 Years
Concord Medical Services Holdings Limited generated $-809M FCF in 2024 (+28% vs 2021). Apple Inc. generated $99B FCF in 2025 (+6% vs 2021).
CCM vs AAPL: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CCM or AAPL a better buy right now?
Apple Inc. (AAPL) offers the better valuation at 35.4x trailing P/E (31.1x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCM or AAPL?
On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 0.9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CCM or AAPL?
Over the past 5 years, Apple Inc. (AAPL) delivered a total return of +110.5%, compared to -90.1% for Concord Medical Services Holdings Limited (CCM). A $10,000 investment in AAPL five years ago would be worth approximately $21K today (assuming dividends reinvested). Over 10 years, the gap is even starker: AAPL returned +1027% versus CCM's -92.1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCM or AAPL?
By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.25β versus Apple Inc.'s 1.28β — meaning AAPL is approximately 413% more volatile than CCM relative to the S&P 500. On balance sheet safety, Apple Inc. (AAPL) carries a lower debt/equity ratio of 167% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.
05Which has better profit margins — CCM or AAPL?
Apple Inc. (AAPL) is the more profitable company, earning 26.9% net margin versus -80.3% for Concord Medical Services Holdings Limited — meaning it keeps 26.9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AAPL leads at 32.0% versus -138.6% for CCM. At the gross margin level — before operating expenses — AAPL leads at 46.9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CCM or AAPL more undervalued right now?
On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 0.9x forward P/E versus 31.1x for Apple Inc. — 30.3x cheaper on a one-year earnings basis.
07Which pays a better dividend — CCM or AAPL?
In this comparison, AAPL (0.4% yield) pays a dividend. CCM does not pay a meaningful dividend and should not be held primarily for income.
08Is CCM or AAPL better for a retirement portfolio?
For long-horizon retirement investors, Concord Medical Services Holdings Limited (CCM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.25)). Both have compounded well over 10 years (CCM: -92.1%, AAPL: +1027%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CCM and AAPL?
These companies operate in different sectors (CCM (Healthcare) and AAPL (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.